Astellas Pharma Aktie
9,46EUR | 0,15EUR | 1,61% |
WKN: 856273 / ISIN: JP3942400007
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 15 883 | 15 455 | 14 522 | 14 484 | 14 754 |
Umsatz pro Mitarbeiter in Mio. EUR | 81,90 | 80,85 | 89,26 | 104,85 | 108,69 |
Bilanz (in Mio. JPY) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 867 514 | 872 588 | 923 354 | 1 049 954 | 1 194 730 |
Summe Anlagevermögen | 1 450 646 | 1 401 040 | 1 409 041 | 1 406 564 | 2 374 873 |
Summe Aktiva | 2 318 160 | 2 273 628 | 2 332 395 | 2 456 518 | 3 569 603 |
Bilanz (in Mio. JPY) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 1 028 990 | 887 514 | 872 086 | 948 564 | 1 973 616 |
Summe Eigenkapital | 1 289 168 | 1 386 115 | 1 460 308 | 1 507 954 | 1 595 988 |
Summe Passiva | 2 318 158 | 2 273 629 | 2 332 394 | 2 456 518 | 3 569 604 |
Adresse
2-5-1 Nihonbashi-Honcho, 103-8411 Tokyo | |
Telefon | +81 (3) 3244-3000 |
Internet | https://www.astellas.com/jp/ |
Management
Eisuke Nozawa
Vice President-Regulatory Affairs |
Eriko Sakurai
Independent Outside Director |
Hideki Shima
Chief Manufacturing Officer |
Katsuyoshi Sugita
Representative Director & Chief People Officer |
Kenji Yasukawa
Chairman |
Kitamura Atsushi
Chief Financial Officer |
Masahiro Miyazaki
Independent Outside Director |
Mika Nakayama
Independent Outside Director |
Naoki Okamura
President, CEO & Representative Director |
Rie Akiyama
Independent Outside Director |
Rika Hirota
Director |
Tadaaki Taniguchi
Chief Medical Officer |
Takashi Tanaka
Independent Outside Director |
Tomoko Aramaki
Independent Outside Director |
Yasuhiro Fujita
Head-Accounting & Global Business Solutions |
Yoichi Ohno
Independent Outside Director |
Yoshitsugu Shitaka
Chief Scientific Officer & Head-Research |